Susquehanna International Group’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Hold
0
-$23.8K 12915
2022
Q4
Sell
-1
Closed -$56.5K 11701
2022
Q3
$90K Sell
1
-1
-50% -$70K ﹤0.01% 11785
2022
Q2
$105K Hold
2
﹤0.01% 11432
2022
Q1
$200K Hold
2
﹤0.01% 11234
2021
Q4
$99K Sell
2
-1
-33% -$83.4K ﹤0.01% 12157
2021
Q3
$388K Hold
3
﹤0.01% 10005
2021
Q2
$453K Sell
3
-3
-50% -$492K ﹤0.01% 9813
2021
Q1
$1.09M Sell
6
-4
-40% -$879K ﹤0.01% 7507
2020
Q4
$1.89M Buy
10
+3
+43% +$464K ﹤0.01% 5218
2020
Q3
$1.08M Buy
7
+1
+17% +$158K ﹤0.01% 5934
2020
Q2
$762K Buy
6
+5
+500% +$611K ﹤0.01% 6490
2020
Q1
$59K Buy
+1
New +$103K ﹤0.01% 9596

Other funds holding GNPX

Susquehanna International Group's GNPX Position: Q4 2025 in Review

Susquehanna International Group sold out of Genprex (GNPX) in Q4 2025, closing a stake of 309 shares — an estimated $57.6K sold.

Susquehanna International Group first reported a position in GNPX in Q1 2020 and held it in 12 quarters. The position peaked at $1.42M in Q1 2021. 9 funds tracked by Wall St. Rank hold GNPX as of Q4 2025.

  • Susquehanna International Group reported no remaining Genprex position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 309 Genprex shares in Q4 2025, an estimated $57.6K.
  • Susquehanna International Group first reported a position in Genprex in Q1 2020 and held it in 12 quarters.
  • Susquehanna International Group's Genprex position peaked at $1.42M in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Genprex as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.